F3 and cancer: The results indicated that the wild-type cells did not have any significant changes (except three involving regulation of actin-based motility by Rho, role of tissue factor in cancer and B-cell receptor signaling) in cellular pathways during the transition from passage 2 to passage 10 (Figure 2A).